Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT05551767 2022-09-23

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Phase 2 Unknown

120 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05025813 2022-08-01

DESQUAMATE

Phase 2 Recruiting

27 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03975036 2019-06-05

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Phase 2/3 Unknown

100 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Phase 1/2 Unknown

58 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

Clinical Trials

SARCO-CTI

A Study of EBC-129 in Advanced Solid Tumours

ACCOMPLISH

NEOPRIME

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

MK3475-C01

ACCESS-I

The Immune Assessment of PD-1 Antibody Therapy in Tumor

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

PEMDAC

Artemis

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

DESQUAMATE

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475